| 
April 20, 2023
Slightly down but mostly flat: Trulieve Cannabis ranged between $5.26 and $5.41 before closing at $5.3.
- United States Existing Home Sales (Mar) is next today at 14:00 UTC.
- Yesterday's fall added to a 5 day bearish run, during which Trulieve Cannabis lost 27 cents.
Earlier data releases related to Trulieve Cannabis – United States Crude Oil Inventories published yesterday at 14:30 UTC came out at -4.58 million, falling short of the -1 million projections and continuing its decline from the previous 597,000 figure. United States 20-Year Bond Auction released yesterday at 17:00 UTC with a figure of 3.92, while the previous figure was 3.909.
Technical analysis of Trulieve Cannabis before macro data is released:
Trulieve Cannabis Corp. could begin to recover as it approaches significant support, now 7 cents away from $5.23. Dipping below could be an indication that further losses are ahead. Despite being in the red so far in the current trading session, Trulieve Cannabis peaked above its 5 day Simple Moving Average around $5.4 — typically an early indicator of a new bullish trend beginning to emerge.
Technical analysis shows that Trulieve Cannabis (currently on a downtrend) might reverse course and start going up in the short term.
Coming up for Trulieve Cannabis — United States Existing Home Sales (Mar) is scheduled for today at 14:00 UTC.
As the markets get ready for more data to be released — Abbott Laboratories traded at $112.29 after closing yesterday's trading day at $104.15 (up 7.82%). Intuitive Surgical traded at $298.57 after closing yesterday's trading day at $269.28 (up 10.88%). Medtronic was up 3.94%.
The leading CBD products developer has recovered 7.65% since descending to a significant low of $4.97 around 9 days ago.
